These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2561145)

  • 21. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effect of spirapril and felodipine during repeated administration to spontaneously hypertensive rats.
    Monopoli A; Forlani A; Milani S; Ongini E
    Pharmacol Res Commun; 1988 Jan; 20(1):37-47. PubMed ID: 2836872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
    Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
    J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients.
    Vaur L; Dutrey-Dupagne C; Boussac J; Genes N; Bouvier d'Yvoire M; Elkik F; Meredith PA
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):127-31. PubMed ID: 7564352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial.
    Hjortkjær HØ; Jensen T; Kofoed KF; Mogensen UM; Sigvardsen PE; Køber L; Hilsted KL; Corinth H; Theilade S; Hilsted J
    BMJ Open; 2016 Dec; 6(12):e012307. PubMed ID: 27920083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
    Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
    Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronological structure of arterial pressure in hypertensive patients on enalapril].
    Gapon LI; Gubin DG; Semukhin EN; Gubin GD
    Klin Med (Mosk); 2001; 79(3):56-9. PubMed ID: 11490421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in left ventricular dimensions and haemodynamics during antihypertensive treatment with spirapril for 36 months.
    Otterstad JE; Froeland G
    Blood Press Suppl; 1994; 2():69-72. PubMed ID: 8061849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP; Lau A; Knaus V; Bauer JH
    J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.
    Krähenbühl S; Grass P; Surve A; Kutz K; Reichen J
    Eur J Clin Pharmacol; 1993; 45(3):247-53. PubMed ID: 8276049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.